Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones.
Lotka–Volterra model
beta-hydroxybutirate
cancer evolution
evolutionary game theory
intratumor clonal heterogeneity
lactate
paracrine signaling
parasitism
Journal
Frontiers in ecology and evolution
ISSN: 2296-701X
Titre abrégé: Front Ecol Evol
Pays: Switzerland
ID NLM: 101633915
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
entrez:
31
1
2022
pubmed:
1
2
2022
medline:
1
2
2022
Statut:
ppublish
Résumé
Explaining the emergence and maintenance of intratumor heterogeneity is an important question in cancer biology. Tumor cells can generate considerable subclonal diversity, which influences tumor growth rate, treatment resistance, and metastasis, yet we know remarkably little about how cells from different subclones interact. Here, we confronted two murine mammary cancer cell lines to determine both the nature and mechanisms of subclonal cellular interactions
Identifiants
pubmed: 35096847
doi: 10.3389/fevo.2021.675638
pmc: PMC8794381
mid: NIHMS1762955
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : U54 CA217376
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Annu Rev Nutr. 2017 Aug 21;37:51-76
pubmed: 28826372
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1833-8
pubmed: 25624490
Nat Rev Cancer. 2020 Mar;20(3):187-198
pubmed: 31932757
Cancer Res. 1988 Oct 15;48(20):5747-53
pubmed: 3167832
Cancer Res. 1978 Oct;38(10):3174-81
pubmed: 210930
Cell. 2019 Aug 22;178(5):1115-1131.e15
pubmed: 31442404
Nat Ecol Evol. 2021 Jun;5(6):826-835
pubmed: 33846605
Nat Rev Clin Oncol. 2020 Nov;17(11):675-686
pubmed: 32699310
PLoS One. 2013 Jun 05;8(6):e65522
pubmed: 23755243
Nature. 2014 Apr 3;508(7494):113-7
pubmed: 24695311
Nat Cell Biol. 2019 Jul;21(7):879-888
pubmed: 31263265
Cancer Control. 2020 Jan-Dec;27(1):1073274820962008
pubmed: 32991214
Int J Cancer. 2014 Oct 1;135(7):1711-20
pubmed: 24615175
Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3287-3294
pubmed: 30486639
Nature. 2012 Oct 25;490(7421):547-51
pubmed: 23023132
Curr Opin Genet Dev. 2011 Feb;21(1):73-9
pubmed: 21106363
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
Nature. 2015 Sep 10;525(7568):261-4
pubmed: 26308893
Int J Cancer. 1991 Feb 1;47(3):466-72
pubmed: 1993557
Nat Rev Cancer. 2006 Dec;6(12):924-35
pubmed: 17109012
Nat Rev Cancer. 2017 Oct;17(10):605-619
pubmed: 28912577
Cancer Cell. 2013 Aug 12;24(2):145-7
pubmed: 23948295
Cancer Res. 1984 Jun;44(6):2259-65
pubmed: 6372991
Cell Death Differ. 2017 Mar;24(3):458-468
pubmed: 27935584
Science. 2013 Jan 11;339(6116):211-4
pubmed: 23223453
Eur J Cancer Clin Oncol. 1989 Mar;25(3):493-7
pubmed: 2703004
Cancer Discov. 2017 Jul 20;:
pubmed: 28729406
Nat Ecol Evol. 2019 Mar;3(3):450-456
pubmed: 30778184
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13474-9
pubmed: 16938860
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Cancer Cell. 2011 Feb 15;19(2):244-56
pubmed: 21316603
Cell Cycle. 2009 Aug;8(15):2347-52
pubmed: 19571677
Evol Appl. 2020 Jul 18;13(7):1558-1568
pubmed: 32821272
Front Endocrinol (Lausanne). 2016 Feb 02;7:5
pubmed: 26869992
Cell Rep. 2014 Aug 7;8(3):688-95
pubmed: 25066122
Nat Rev Cancer. 2015 Aug;15(8):473-83
pubmed: 26156638
Anticancer Res. 1996 May-Jun;16(3B):1417-27
pubmed: 8694510
Nat Commun. 2017 Mar 10;8:14706
pubmed: 28281525
J Cell Biol. 2012 Feb 20;196(4):395-406
pubmed: 22351925
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):162-166
pubmed: 28341421
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609
Nat Commun. 2020 Nov 16;11(1):5799
pubmed: 33199705